A few weeks ago we did a story detailing the many gold ETFs and miners that famous hedge funds have been holding and losing in. The article mentioned the hedge fund titan Seth Klarman a couple of times as he has been bullish on gold for as long as one can remember.
Seth Klarman’s Losses in Gold Miners
Nathan Vardi at Forbes points out that NovaGold is not the only gold equity holdings that Klarman is losing on (it is important to note these are paper returns not realized losses). Baupost Group has significant stakes in foreign listed gold miners as well. The fund owns 19.7 percent stake in a Toronto based gold miner, Guyana Goldfields Inc. (TSE:GUY). This would amount to a position in 24,847, 600 shares. As Guyana Goldfields Inc. (TSE:GUY) is down 54 percent YTD, Klarman has lost some $46 million on the investment.
Guyana Goldfields is currently engaged in closing the funding gap for its Aurora project in Guyana which is estimated to be at $160-$180 million. Options to raise these funds include streaming transaction, forward sales or an additional round of equity.
Moving on to the other gold holdings of Klarman, NovaGold Resources Inc. (TSE:NG) (NYSEMKT:NG) has lost 55 percent YTD. Baupost Group holds 21,688,300 shares of the miner and has wiped $63 million off of its portfolio as the shares plummeted through most of the year.
Other foreign gold miners that have adorned Baupost’s book are Romanian based Gabriel Resources LT (OTCMKTS:GBRRF) and Carpathian Gold Inc (OTCMKTS:CPNFF). Baupost owns 13 percent of Gabriel and 19 percent of Carpathian Gold. Unsurprisingly both of these miners have not done well amid tapering fears and China slowdown. Klarman took some $38 million in paper losses in the 50,000,000 shares he owns of Gabriel Resources LT (OTCMKTS:GBRRF), shares have lost 33 percent for this year. Klarman’s investment in 105,530,000 shares of Carpathian Gold Inc (OTCMKTS:CPNFF) took a loss of $17 million, which is down 49 percent YTD.
ViaSat, Theravance Bag 90% Gains
Notwithstanding losses from gold miners, Klarman has done more than well in his other long holdings. The second largest position of Baupost public portfolio, ViaSat, Inc. (NASDAQ:VSAT) is up 80 percent YTD, meaning that hedge fund has gained a cool $310 million on paper from the company.
Baupost has done much better in its wide variety of biotech and pharma holdings. Theravance Inc (NASDAQ:THRX), another top equity holding, has netted a whopping 98 percent gain over the year, making the fund some $271 million richer. Elan Corporation, plc (NYSE:ELN) is up 40 percent YTD, a position that Baupost added in Q1. American International Group Inc (NYSE:AIG), Baupost’s third largest holding is up 33 percent YTD, smoothly adding a $100 million profit to his long book.
Other positive performers have been Rovi Corporation (NASDAQ:ROVI), whereas detractors have been Idenix Pharmaceuticals Inc (NASDAQ:IDIX), down 27 percent YTD and Oracle Corporation (NASDAQ:ORCL) whose shares have lost 2 percent YTD.
The above companies make up only a fraction of Klarman’s $28 billion fund, gathering up to equal less than $4 billion in market value. However they surely give insight into how well Klarman’s bets have worked.